- Home
- MOVE vs APRE Comparison
MOVE vs APRE Comparison
Compare MOVE & APRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- APRE
- Stock Information
- Founded
- MOVE 2018
- APRE 2006
- Country
- MOVE United States
- APRE United States
- Employees
- MOVE N/A
- APRE N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MOVE Health Care
- APRE Health Care
- Exchange
- MOVE Nasdaq
- APRE Nasdaq
- Market Cap
- MOVE 25.9M
- APRE 21.3M
- IPO Year
- MOVE 2021
- APRE 2019
- Fundamental
- Price
- MOVE $3.26
- APRE $3.25
- Analyst Decision
- MOVE Buy
- APRE Strong Buy
- Analyst Count
- MOVE 1
- APRE 2
- Target Price
- MOVE $30.00
- APRE $15.50
- AVG Volume (30 Days)
- MOVE 62.0K
- APRE 15.3K
- Earning Date
- MOVE 11-14-2024
- APRE 11-07-2024
- Dividend Yield
- MOVE N/A
- APRE N/A
- EPS Growth
- MOVE N/A
- APRE N/A
- EPS
- MOVE N/A
- APRE N/A
- Revenue
- MOVE $902,000.00
- APRE $1,310,839.00
- Revenue This Year
- MOVE N/A
- APRE $116.72
- Revenue Next Year
- MOVE $443.49
- APRE N/A
- P/E Ratio
- MOVE N/A
- APRE N/A
- Revenue Growth
- MOVE N/A
- APRE 130.31
- 52 Week Low
- MOVE $3.01
- APRE $2.15
- 52 Week High
- MOVE $14.70
- APRE $8.85
- Technical
- Relative Strength Index (RSI)
- MOVE 33.01
- APRE 40.43
- Support Level
- MOVE $3.76
- APRE $3.15
- Resistance Level
- MOVE $4.28
- APRE $4.15
- Average True Range (ATR)
- MOVE 0.48
- APRE 0.34
- MACD
- MOVE -0.03
- APRE -0.12
- Stochastic Oscillator
- MOVE 15.47
- APRE 13.97
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.